ALNOV — Novacyt SA Share News
0.000.00%
- €27.16m
- €12.44m
- £19.63m
REG - Novacyt S.A. - Result of Preferential Subscription Rights Issue
AnnouncementREG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR
AnnouncementREG - Novacyt S.A. - Preferential Subscription Rights Issue
AnnouncementREG - Novacyt S.A. - Completion of Acquisition
AnnouncementREG - Novacyt S.A. - Acquisition of Southern Cross Diagnostics
AnnouncementREG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR
AnnouncementREG - Novacyt S.A. - NIPT Tender Award
AnnouncementREG - Novacyt S.A. - Full year trading update
AnnouncementREG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR
AnnouncementREG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR
AnnouncementREG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR
AnnouncementREG - Novacyt S.A. - Strategy update & notice of investor presentation
AnnouncementREG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR
AnnouncementREG - Cardiogeni PLC - Annual Results to 31 March 2025
AnnouncementREG - Novacyt S.A. - 2025 Interim results
AnnouncementREG - Novacyt S.A. - Notice of Results
AnnouncementREG - Novacyt S.A. - Appointment of Joint Corporate Broker
AnnouncementREG - Novacyt S.A. - Resolution re. Lab 21 HSE Prosecution
AnnouncementREG - Novacyt S.A. - Liquidity Agreement Monthly Update and TVR
Announcement